FDA Drug recall D-0009-2022
Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection, 1 mg per vial
- FDA Drug
- Class I
- terminated
- Published 2021-10-20
On 2021-10-20 the FDA classified a Class I recall of Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection, 1 mg per vial by Eli Lilly And, citing SUBPOTENT DRUG: Vial contained a liquid substance, instead of the expected powder substance. There was also a lack of full drug effect upon administration.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0009-2022 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2021-09-24 |
| Published | 2021-10-20 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Eli Lilly And |
| Distribution | US |
Product
Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection, 1 mg per vial; Diluent for Glucagon, 1 mL syringe. Rx only, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285; Glucagon, NDC: 0002-8031-01
Reason
SUBPOTENT DRUG: Vial contained a liquid substance, instead of the expected powder substance. There was also a lack of full drug effect upon administration.
Identifiers
| code_info | Lot #: D239382D, Exp. Date April 2022 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0009-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.